Secondary hemophagocytic lymphohistiocytosis associated with meningococcemia.
Dinleyici
Ener Cagri
EC
Eskisehir Osmangazi University Faculty of Medicine, Department of Pediatrics and Microbiology, Eskisehir, Turkey.
Bor
Ozcan
O
Kiremitci
Abdurrahman
A
Aksit
M Arif
MA
D000293:Adolescent; D016470:Bacteremia / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy; D002443:Ceftriaxone / Q000627:therapeutic use; D003131:Combined Modality Therapy; D003907:Dexamethasone / Q000627:therapeutic use; D004298:Dopamine / Q000627:therapeutic use; D017809:Fatal Outcome; D005260:Female; D006801:Humans; D051359:Lymphohistiocytosis, Hemophagocytic / Q000097:blood / Q000209:etiology* / Q000628:therapy; D008585:Meningitis, Meningococcal / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy; D008589:Meningococcal Infections / Q000150:complications* / Q000175:diagnosis / Q000188:drug therapy; D010406:Penicillins / Q000627:therapeutic use; D010949:Plasma; D017713:Platelet Transfusion; D012121:Respiration, Artificial; D014640:Vancomycin / Q000627:therapeutic use
D010406:Penicillins; D014640:Vancomycin; D002443:Ceftriaxone; D003907:Dexamethasone; D004298:Dopamine